NDA.FI

15.86

-0.56%↓

BKT

14.24

-0.07%↓

FCFS

213.74

-1.21%↓

RAND

25.35

+0.72%↑

NDA.FI

15.86

-0.56%↓

BKT

14.24

-0.07%↓

FCFS

213.74

-1.21%↓

RAND

25.35

+0.72%↑

NDA.FI

15.86

-0.56%↓

BKT

14.24

-0.07%↓

FCFS

213.74

-1.21%↓

RAND

25.35

+0.72%↑

NDA.FI

15.86

-0.56%↓

BKT

14.24

-0.07%↓

FCFS

213.74

-1.21%↓

RAND

25.35

+0.72%↑

NDA.FI

15.86

-0.56%↓

BKT

14.24

-0.07%↓

FCFS

213.74

-1.21%↓

RAND

25.35

+0.72%↑

Search

Sartorius Stedim Biotech.

Open

BrancheFinanzen

153.6 -3.4

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

150.6

Max

160.2

Schlüsselkennzahlen

By Trading Economics

Einkommen

41M

88M

Verkäufe

-11M

762M

KGV

Branchendurchschnitt

58.498

37.736

EPS

1.17

Gewinnspanne

11.569

Angestellte

10,456

EBITDA

26M

225M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+45.9% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

23. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-2.6B

16B

Vorheriger Eröffnungskurs

157

Vorheriger Schlusskurs

153.6

Nachrichtenstimmung

By Acuity

25%

75%

66 / 439 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Sartorius Stedim Biotech. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Apr. 2026, 23:33 UTC

Heiße Aktien

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28. Apr. 2026, 23:24 UTC

Ergebnisse

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28. Apr. 2026, 23:15 UTC

Wichtige Nachrichtenereignisse

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28. Apr. 2026, 22:46 UTC

Ergebnisse

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28. Apr. 2026, 22:37 UTC

Ergebnisse

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28. Apr. 2026, 22:15 UTC

Ergebnisse
Wichtige Nachrichtenereignisse

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28. Apr. 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28. Apr. 2026, 23:31 UTC

Ergebnisse

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28. Apr. 2026, 23:31 UTC

Ergebnisse

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28. Apr. 2026, 23:30 UTC

Ergebnisse

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28. Apr. 2026, 23:30 UTC

Ergebnisse

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28. Apr. 2026, 23:19 UTC

Market Talk
Ergebnisse

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28. Apr. 2026, 23:09 UTC

Ergebnisse

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28. Apr. 2026, 23:03 UTC

Market Talk

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

NIESR Sees One Rate Rise to 4% in Benign Scenario

28. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28. Apr. 2026, 23:01 UTC

Wichtige Nachrichtenereignisse

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28. Apr. 2026, 22:51 UTC

Ergebnisse

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28. Apr. 2026, 22:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. Apr. 2026, 22:48 UTC

Market Talk

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28. Apr. 2026, 22:40 UTC

Market Talk
Wichtige Nachrichtenereignisse

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28. Apr. 2026, 22:32 UTC

Ergebnisse

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28. Apr. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28. Apr. 2026, 22:22 UTC

Ergebnisse

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28. Apr. 2026, 22:17 UTC

Market Talk

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28. Apr. 2026, 22:14 UTC

Ergebnisse

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28. Apr. 2026, 22:14 UTC

Ergebnisse

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28. Apr. 2026, 22:07 UTC

Market Talk
Wichtige Nachrichtenereignisse

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Peer-Vergleich

Kursveränderung

Sartorius Stedim Biotech. Prognose

Kursziel

By TipRanks

45.9% Vorteil

12-Monats-Prognose

Durchschnitt 233 EUR  45.9%

Hoch 262 EUR

Tief 210 EUR

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sartorius Stedim Biotech. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

202.7 / 211.7Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

66 / 439 Ranking in Finanzen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat